008930 — Hanmi Science Share News
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩1tn
Brief: Hanmi Science Q4 Operating Profit 37.6 Billion Won, Up 197.4% From Year Earlier
Brief: Hanmi Science Q3 Operating Profit 39.3 Billion Won, Up 75% From Year Earlier
Brief: Hanmi's Oral Delivery Platform Compound Licensed to Gilead
Brief: Hanmi's Oral Delivery Platform Compound Licensed to Gilead
Brief: Hanmi Science Q2 Operating Profit 34.6 Billion Won, Up 30.7% From Year Earlier
Brief: Hanmi Science Co Ltd Q3 Operating Profit 22 Billion Won, Down 37% From Year Earlier
Brief: Hanmi Science Q2 Operating Profit 26.6 Billion Won, Up 0.5% From Year Earlier
Brief: Hanmi Science Q1 Operating Profit 37.3 Billion Won, Up 19% From Year Earlier
Brief: Hanmi Science Co Ltd To Cancel 33 Billion Won Worth Of Own Shares
Brief: Hanmi Science To Pay Dividend Of 200 Won Per Common Share
Brief: Hanmi Science Plans To Use 50% Of Net Profit As Source Of Shareholder-Friendly Policies
Brief: Hanmi Science Q3 Operating Profit 36 Billion Won, Up 113% From Year Earlier
Brief: Hanmi Science Q2 Operating Profit 27.3 Billion Won, Up 72.8% From Year Earlier
Brief: Hanmi Science Co Q1 Operating Profit 31 Billion Won, Up 59% From Year Earlier
Brief: Hanmi Science Q4 Operating Profit 14 Billion Won, Up 6% From Year Earlier
Brief: Hanmi Science Q2 Operating Profit 16 Billion Won, Up 20% From Year Earlier
Private S.Korea firms plan $5.4 bln investment to create vaccine hub
S.Korea in talks with mRNA vaccine makers to make up to 1 bln doses -govt official
S.Korea in talks with mRNA vaccine makers to make up to 1 bln doses -govt official